Anti-Cancer Drugs

An International Journal on Anti-Cancer Agents
Anti-Cancer Drugs 09594973
ISBN/ISSN: 09594973
Term (Number of years)
Quantity
Select a Price:

Select a Country:
  close

Journal Pricing

The following options and terms will help you in choosing your LWW subscription.
Single Issues:   You can order single issues of most journals. Pricing and ordering information are available here.
Institutional Rates:   These rates apply to libraries, hospitals, corporations, and partnerships of three (3) or more individuals.
International Rates:   International rates apply when the final destination of the subscription lies in Canada, Mexico, and all other countries outside the U.S.
Handling Charge:   A handling charge must be added to the rate of most LWW periodical publications. See the "Plus Handling" column on the journal rate sheet.
Air Freight Charge:   Most Lippincott Williams & Wilkins periodicals are shipped via air freight service to destinations outside U.S., Canada, and Mexico. Please refer to the journal rate sheet to determine the titles with an "Overseas Shipping" charge. Where applicable, this charge IS NOT OPTIONAL and must be added to all subscription rates for countries outside the United States, Canada, and Mexico. Canadian subscribers must add GST or HST as applicable.
For other purchasing options and tools available for LWW journals, please visit the Periodical Center.

 





Promotion Code
Apply

Avoid future price increases! Lock in the current rate for up to 3 years. Select your preferred number of years and click "Subscribe".

All individual subscriptions include online access to the journal, which can be accessed through http://journals.lww.com.

 

Description

Anti-Cancer Drugs provides current information on the clinical and experimental effects of toxic and non-toxic cancer agents and is specifically directed towards breakthroughs in cancer treatment. Among the topics included are cytotoxic chemotherapy, hormonal or biological response modifiers such as interleukins, immunotherapy, drug design, adverse effects of drugs and drug resistance. Within the journal, strong emphasis is placed on papers reporting treatments to alleviate the side-effects of chemotherapy.

2012 Impact factor 2.232*.

Now with iPad app! Individual subscriptions include print copies, online access and digital editions on your iPad.

*2012 Journal Citation Reports® (Thomson Reuters, 2013)

Features

--Original clinical reports
--Preclinical reports
--Review articles
--Case reports
--Commentary
--Meeting reports
--Fast publication time
--Provides new developments and breakthrough research

--2012 Impact Factor: 2.232*
--2012 Ranking: 115 of 196 Oncology, 127 of 260 Pharmacology & Pharmacy*
--Website: www.anti-cancerdrugs.com
 
*2012 Journal Citation Reports® (Thomson Reuters, 2013)

About the Editor(s)

Specs

  • ISSN: 09594973
  • Published: Published 10 times per year

Associated Specialties